Skip to main content
OpenTrials

Clinical trial condition

Blastic Phase Chronic Myelogenous Leukemia

Explore clinical trials studying Blastic Phase Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

41 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Blastic Phase Chronic Myelogenous Leukemia trial results

Completed

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

NCT03647215

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Limerick University Hospital Limerick, Dooradoyle, Ireland
  • University Hospital Waterford Waterford, Ireland
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Royal Devon & Exeter Hospital Exeter, Devon, United Kingdom
View all 33 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

NCT00089011

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
Locations
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

NCT00702403

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blast Crisis, +36 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium Tampa, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

NCT00112593

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions